Sort   by:  
 Page size 
UnknownDominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.
Not available
S-EPMC11364440 | biostudies-literature
Unknown15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN.
Not available
S-EPMC12909123 | biostudies-literature
UnknownRegional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.
Not available
S-EPMC12260115 | biostudies-literature
UnknownHuman fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.
Not available
S-EPMC6060509 | biostudies-literature
UnknownEffects of Pu-erh and Dian Hong tea polyphenols on the gut-liver axis in mice.
Not available
S-EPMC10236074 | biostudies-literature
UnknownPositron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN).
Not available
S-EPMC10400428 | biostudies-literature
UnknownDownstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Not available
S-EPMC11059071 | biostudies-literature
UnknownSafety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial.
Not available
S-EPMC11838922 | biostudies-literature
Unknownγ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
Not available
S-EPMC11822357 | biostudies-literature
UnknownCross-Species Insights from ART-D to Uncover Evolutionarily Conserved Oncogenic Mechanisms
Not available
S-SCDT-10_1038-S44320-026-00215-8 | biostudies-other
Sort   by:  
 Page size